Neprilysin inhibition in heart failure: mechanisms and substrates beyond modulating natriuretic peptides
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Neprilysin inhibition in heart failure: mechanisms and substrates beyond modulating natriuretic peptides
Authors
Keywords
-
Journal
EUROPEAN JOURNAL OF HEART FAILURE
Volume 19, Issue 6, Pages 710-717
Publisher
Wiley
Online
2017-03-23
DOI
10.1002/ejhf.799
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Therapeutic options of Angiotensin Receptor Neprilysin inhibitors (ARNis) in chronic heart failure with reduced ejection fraction: Beyond RAAS and sympathetic nervous system inhibition
- (2017) Maurizio Volterrani et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Angiotensin receptor–neprilysin inhibitor (ARNi): Clinical studies on a new class of drugs
- (2017) Mauro Gori et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Importance of endogenous compensatory vasoactive peptides in broadening the effects of inhibitors of the renin-angiotensin system for the treatment of heart failure
- (2017) Milton Packer et al. LANCET
- Plasma bioactive adrenomedullin as a prognostic biomarker in acute heart failure
- (2016) Wesley H. Self et al. AMERICAN JOURNAL OF EMERGENCY MEDICINE
- Developing New Treatments for Heart Failure
- (2016) Mihai Gheorghiade et al. Circulation-Heart Failure
- Soluble neprilysin does not correlate with outcome in heart failure with preserved ejection fraction
- (2016) Georg Goliasch et al. EUROPEAN JOURNAL OF HEART FAILURE
- Kicking the tyres of a heart failure trial: physician response to the approval of sacubitril/valsartan in the USA
- (2016) Milton Packer EUROPEAN JOURNAL OF HEART FAILURE
- Efficacy of sacubitril/valsartan vs. enalapril at lower than target doses in heart failure with reduced ejection fraction: the PARADIGM-HF trial
- (2016) Orly Vardeny et al. EUROPEAN JOURNAL OF HEART FAILURE
- Initiating sacubitril/valsartan (LCZ696) in heart failure: results of TITRATION, a double-blind, randomized comparison of two uptitration regimens
- (2016) Michele Senni et al. EUROPEAN JOURNAL OF HEART FAILURE
- Dementia-related adverse events in PARADIGM-HF and other trials in heart failure with reduced ejection fraction
- (2016) Jane A. Cannon et al. EUROPEAN JOURNAL OF HEART FAILURE
- 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
- (2016) Piotr Ponikowski et al. EUROPEAN JOURNAL OF HEART FAILURE
- The neprilysin pathway in heart failure: a review and guide on the use of sacubitril/valsartan
- (2016) Pardeep S Jhund et al. HEART
- Prognostic Implications of Changes in N-Terminal Pro-B-Type Natriuretic Peptide in Patients With Heart Failure
- (2016) Michael R. Zile et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- A Test in Context: Neprilysin
- (2016) Antoni Bayes-Genis et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Plasma levels of intermedin (adrenomedullin-2) in healthy human volunteers and patients with heart failure
- (2016) David Bell et al. PEPTIDES
- Prognostic Significance of Adrenomedullin in Patients With Heart Failure and With Myocardial Infarction
- (2015) Matthew F. Yuyun et al. AMERICAN JOURNAL OF CARDIOLOGY
- Contemporary Drug Development in Heart Failure
- (2015) Muthiah Vaduganathan et al. Circulation-Heart Failure
- Biomarkers of activation of renin-angiotensin-aldosterone system in heart failure: how useful, how feasible?
- (2015) Michele Emdin et al. CLINICA CHIMICA ACTA
- The natriuretic peptides system in the pathophysiology of heart failure: from molecular basis to treatment
- (2015) M. Volpe et al. CLINICAL SCIENCE
- Effect of the angiotensin-receptor-neprilysin inhibitor LCZ696 compared with enalapril on mode of death in heart failure patients
- (2015) Akshay S. Desai et al. EUROPEAN HEART JOURNAL
- Efficacy and safety of LCZ696 (sacubitril-valsartan) according to age: insights from PARADIGM-HF
- (2015) Pardeep S. Jhund et al. EUROPEAN HEART JOURNAL
- Neprilysin inhibition to treat heart failure: a tale of science, serendipity, and second chances
- (2015) John J.V. McMurray EUROPEAN JOURNAL OF HEART FAILURE
- Role of biomarkers in cardiac structure phenotyping in heart failure with preserved ejection fraction: critical appraisal and practical use
- (2015) Emilia D'Elia et al. EUROPEAN JOURNAL OF HEART FAILURE
- Circulating biomarkers of distinct pathophysiological pathways in heart failure with preserved vs. reduced left ventricular ejection fraction
- (2015) S. Sanders-van Wijk et al. EUROPEAN JOURNAL OF HEART FAILURE
- An update of the blockade of the renin angiotensin aldosterone system in clinical practice
- (2015) Diego F Márquez et al. EXPERT OPINION ON PHARMACOTHERAPY
- Soluble Neprilysin Is Predictive of Cardiovascular Death and Heart Failure Hospitalization in Heart Failure Patients
- (2015) Antoni Bayés-Genís et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Endothelial C-type natriuretic peptide maintains vascular homeostasis
- (2014) Amie J. Moyes et al. JOURNAL OF CLINICAL INVESTIGATION
- Meta-analysis of the association between two neprilysin gene polymorphisms and Alzheimer's disease
- (2014) Xingzhi Guo et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Neprilysin Inhibition — A Novel Therapy for Heart Failure
- (2014) Mariell Jessup NEW ENGLAND JOURNAL OF MEDICINE
- Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure
- (2014) John J.V. McMurray et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rationale and study design of the Prospective comparison of Angiotensin Receptor neprilysin inhibitor with Angiotensin receptor blocker MEasuring arterial sTiffness in the eldERly (PARAMETER) study
- (2014) Bryan Williams et al. BMJ Open
- The Renin-Angiotensin-Aldosterone System and Heart Failure
- (2013) Gabriel Sayer et al. CARDIOLOGY CLINICS
- Substance P in heart failure: The good and the bad
- (2013) Heather M. Dehlin et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: a phase 2 double-blind randomised controlled trial
- (2012) Scott D Solomon et al. LANCET
- Comparison of Mass Spectrometry and Clinical Assay Measurements of Circulating Fragments of B-Type Natriuretic Peptide in Patients With Chronic Heart Failure
- (2011) Wayne L. Miller et al. Circulation-Heart Failure
- C-type Natriuretic Peptide (CNP): Cardiovascular Roles and Potential as a Therapeutic Target
- (2011) Natalie G. Lumsden et al. CURRENT PHARMACEUTICAL DESIGN
- Aβ-Degrading Enzymes: Potential for Treatment of Alzheimer Disease
- (2011) James Scott Miners et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Mid-Region Pro-Hormone Markers for Diagnosis and Prognosis in Acute Dyspnea
- (2010) Alan Maisel et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- New Aspects for the Treatment of Cardiac Diseases Based on the Diversity of Functional Controls on Cardiac Muscles: The Regulatory Mechanisms of Cardiac Innervation and Their Critical Roles in Cardiac Performance
- (2009) Masaki Ieda et al. JOURNAL OF PHARMACOLOGICAL SCIENCES
- Detection of Endogenous B-Type Natriuretic Peptide at Very Low Concentrations in Patients With Heart Failure
- (2008) Eric E. Niederkofler et al. Circulation-Heart Failure
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started